|
NEWS, EVENTS, and DEADLINES
October 3, 2024
| |
Introducing NJ ACTS GREAT Element | |
|
Have you thought about including a genetic component in your project, but did not know how to go about it or who you might turn to for help?
The GREAT Core is a new component of NJ ACTS, providing consultations, training and services for conducting genetically informed research in diverse populations. It addresses the challenges of integrating genetics into research, such as ethical concerns and effective communication of genetic findings to participants. The program will provide tailored support, mentoring, and education on the role of genetics in health risks and treatments, emphasizing community engagement and genetic counseling. This initiative will also work closely with other departments to integrate genomic data into clinical research and develop strategies for better community engagement regarding genetic testing. The goal is to create a cohesive approach that improves research quality and patient care.
The GREAT team has extensive expertise in various genetic research methods and will collaborate with existing Rutgers and Princeton resources to offer flexible consultation. GREAT is led by Carlos Pato, MD, Gary Heiman, PhD and Jessica Salvatore, PhD and includes Jennifer Mulle, PhD, Michele Pato, MD, Zhi Wei, PhD and Dantong Yu, PhD.
Visit the GREAT webpage
| |
Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events | |
|
Research Resources
Workshop Wednesday (R2W2) Series
NJ ACTS and Research Resources
Offered as part of the ongoing R2W2 series, this session will provide an overview of the resources and services available through NJ ACTS, the Rutgers-led Clinical and Translational Science Award.
| |
presented by
Reynold Panettieri Jr, MD
| |
|
October 16, 2024
4 - 5 pm
| | | |
Rutgers Health Partners with NIH | |
|
Researchers Aim to Pull Back the Curtain
on Long COVID in Kids
Rutgers Health partners in the National Institutes of Health's effort to characterize the long-term effects of the virus on young patients
In the most comprehensive national study since the onset of the COVID-19 pandemic, a team of researchers, led at Rutgers by Lawrence Kleinman, MD, RWJMS, that includes a Rutgers-organized consortium of pediatric sites has concluded that long COVID symptoms in children are tangible, pervasive, wide-ranging, and clinically distinct within specific age groups. Results of the study, funded by the National Institutes of Health (NIH), are published in the Journal of the American Medical Association.
While more work is needed to understand long COVID's symptoms in the youngest patients and to develop effective treatment protocols, the latest findings leave no doubt that long COVID in children is real. Some children are severely affected; they are not faking it or making it up.
Read the full article
| |
New Jersey Kids Study Needs Volunteers | |
|
The New Jersey Kids Study has just launched its pilot study to assess exposures that affect children's health. They are hoping to enroll pregnant people in their first trimester in this IRB-approved study.
Discover more about the New Jersey Kids Study at njks.rutgers.edu
| |
|
Based on research by Dr. Jessica E. Salvatore, NJ.com published an article about how high school students’ genes can influence how likely their peers are to abuse drugs or alcohol or be depressed or anxious. The research is part of the relatively new field of socio-genetics, which looks at the influences of inherited traits on others.
Associate Professor Jessica E. Salvatore and four co-authors dove into a comprehensive database of more than 655,000 people in Sweden who were ages 17 to 30, plus their relatives going back to great-great-grandparents.
Dr. Salvatore is a Co-Lead in the new UM1 Element Genetically informed Research, Education, And Treatment (GREAT)
| |
NCATS, NIH, and Federal News and Events | |
|
NCATS Strategic Plan for 2025–2030
| |
Collaboration Webinars from the
Hear from CTSA TIN experts on various trial-related topics to improve your project.
| |
|
A Mobile Device URL IRL: Innovating Multisite Study Recruitment with the Clinician Study "App"
Multisite clinical research success rests with a strong study recruitment toolbox. One innovative tool that provides up-to-date study information to clinicians across study sites and referring clinics is the Clinician Study App—or CSA. The CSA functions like an app on the web browser of any mobile device.
October 7, 2024
12 pm
| |
|
Adaptive Clinical Trial Designs: From Basics to Bayesian
As resources become increasingly limited, adaptive clinical trial designs have been proposed to conduct more efficient translational research. These designs include elements to stop trials before completion for futility, efficacy, or safety; adapt the allocation across study arms; enrich the population enrolled; revise target sample sizes; or to add/drop study arms.
November 20, 2024
12 pm
| |
|
NJ ACTS Publication Highlights
Protective role of the placental efflux transporter BCRP/ABCG2 in the relationship between prenatal cadmium exposure, placenta weight, and size at birth. Emily S Barrett, Zorimar Rivera-Núñez, Kylie Getz, Pamela Ohman-Strickland, Ranran Zhang, Danielle Kozlosky, Cathleen L Doherty, Brian T Buckley, Jessica Brunner, Richard K Miller, Thomas G O’Connor, Lauren M Aleksunes. Environ Res. 2023 May 15;225:115597. doi: 10.1016/j.envres.2023.115597. Epub 2023 Mar 1.
The consideration of post-exercise impact on SCAT3 scores in athletes immediately following a head injury. Stephanie Iring-Sanchez, Jenna Tosto, Michelle Favre, Sinae Kim, Michael Falvo, Jorge M Serrador. Brain Injury. 2023 Mar 24;1-12. doi: 10.1080/02699052.2023.2184868. Online ahead of print.
| | |
|
New Jersey Institute of Technology has earned a minority-serving institution (MSI) designation from the U.S. Department of Education. Under the umbrella MSI designation, NJIT has qualified as an Asian American Native American Pacific Islander Serving Institution (AANAPISI) with more than 20% of undergraduate students identifying as Asian American or Pacific Islander (AAPI). Read the Full Article | |
ResearchMatch is now available in simplified Chinese! Volunteers are now able to sign up with ResearchMatch and view the website in simplified Chinese in addition to English and Spanish. | |
NIH 2024 DataWorks! Prize. Rewarding new and innovative approaches to data sharing and reuse in research. View Website and Apply by October 23rd. Total cash prizes: $500,000 | |
NSF I-Corps Teams Q&A Webinar. I-Corps Teams is an intensive 7-week boot camp that covers key concepts related to testing and building a business model. Register for the October 3rd Q&A, 12 - 1 pm | |
NIH Environmental Justice (EJ) Scholars Program - Mid‐career to senior scientist candidates and environmental justice community leaders from academic, non‐profit, or private sectors are eligible to apply for the inaugural 2024–2025 cohort. Application Deadline: October 11, 2024 | |
NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
| |
|
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UM1TR004789 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
Send story ideas to NJACTS@rbhs.rutgers.edu
UL1TR003017 (pre-5/1/2024), UM1TR004789 (starting 5/1/2024), KL2TR003018 and TL1TR003019
| | | | |
